Innate Pharma Announces Conference Call and Webcast
Innate Pharma Announces Conference Call and Webcast
Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Friday, August 14, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT.
Participants during the call will be:
Jonathan Dickinson, Chief Executive Officer
Innate Pharma to participate in the Jefferies Global Healthcare Conference
Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
Outcome of Innate Pharma’s 2026 Annual General Meeting
Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan…
Innovative Industrial Properties Announces Second Quarter 2026 Earnings Release Date and Conference Call
Medincell: Videoconference and Publication of Annual Financial Results, Tuesday, June 16, 2026
